Literature DB >> 16565143

Approval of inhaled insulin in Europe and United States.

Bruce Charlesworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16565143      PMCID： PMC1410856          DOI： 10.1136/bmj.332.7543.730-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Inhaled insulin is approved in Europe and United States.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2006-02-11

2.  Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Teresa Quattrin; André Bélanger; Nancy J V Bohannon; Sherwyn L Schwartz
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

3.  Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

Authors:  Jay S Skyler; Ruth S Weinstock; Philip Raskin; Jean-François Yale; Eugene Barrett; John E Gerich; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

4.  Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Priscilla A Hollander; Lawrence Blonde; Richard Rowe; Adi E Mehta; Joseph L Milburn; Kenneth S Hershon; Jean-Louis Chiasson; Seymour R Levin
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.